> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Torrent Pharma Recalls Anagrelide Due to Dissolution
- URL: https://www.fdaweb.com/torrent-pharma-recalls-anagrelide-due-to-dissolution/
- Published: 2020-12-10T12:00:00.000Z
- Updated: 2026-09-14T16:39:43.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5148275

Torrent Pharmaceuticals has recalled one lot of anagrelide capsules due to a dissolution test failure detected during routine quality testing. “Failed dissolution can result in a slower rate and extent of drug release leading to less anagrelide available in the body,” a [recall notice](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/torrent-pharmaceuticals-limited-issues-voluntary-nationwide-recall-anagrelide-capsules-usp-due?ref=fdaweb.com) says. “For seriously ill patients with elevated platelet counts, less available anagrelide could increase the risk of clotting (blood coagulation) and clotting or bleeding events such as a heart attack or stroke which could be life-threatening.” Anagrelide is used to treat thrombocythemia (also called thrombocytosis), a blood cell disorder which occurs when the body produces too many platelet cells.